nVerses Capital’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
SCM
QF
DCM
GECH
nVerses Capital's ATEX Position: Q4 2024 in Review
nVerses Capital sold out of Anterix (ATEX) in Q4 2024, closing a stake of 1,200 shares — an estimated $45.2K sold.
nVerses Capital first reported a position in ATEX in Q3 2024 and held it in 1 quarter. The position peaked at $45.2K in Q3 2024. 115 funds tracked by Wall St. Rank hold ATEX as of Q4 2024.
- nVerses Capital reported no remaining Anterix position as of Q4 2024 after selling out during the quarter.
- nVerses Capital sold 1,200 Anterix shares in Q4 2024, an estimated $45.2K.
- nVerses Capital first reported a position in Anterix in Q3 2024 and held it in 1 quarter.
- nVerses Capital's Anterix position peaked at $45.2K in Q3 2024.
- 115 funds tracked by Wall St. Rank held Anterix as of Q4 2024.
Based on nVerses Capital's 13F filing for Q4 2024.